PROCYSBI
NDC 75987-101, Cysteamine bitartrate, capsule, delayed release pellets, from Horizon Therapeutics USA, Inc..
- Product NDC
- 75987-101
- Status
- Listed
- Labeler
- Horizon Therapeutics USA, Inc.
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203389
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75987-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYSTEAMINE BITARTRATE75 mg/1
Pharmacologic classes
Cystine Depleting Agent [EPC]; Cystine Disulfide Reduction [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75987-101-08 | 75987010108 | 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (75987-101-08) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d3a3ec28-f746-463a-bb92-3bc8826db09e
Use it
Look up 75987-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75987-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75987-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.